Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid

Blood

Volumn 87, Issue 9, 1996, Pages 3650-3654

  Estey, Elihu ^a   Thall, Peter F ^b   Mehta, Kapil ^b   Rosenblum, Michael ^b   Brewer Jr , Tim ^b   Simmons, Veronica ^b   Cabanillas, Fernando ^b   Kurzrock, Razelle ^b   Lopez Berestein, Gabriel ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

L ATRA; LIPOSOME; RETINOIC ACID; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; AREA UNDER THE CURVE; ARTICLE; B CELL LYMPHOMA; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRY SKIN; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HYPOTENSION; MYELODYSPLASTIC SYNDROME; PHARMACEUTICS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; RECURRENCE RISK; T CELL LYMPHOMA;

EID: 0029933428     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.3650.bloodjournal8793650     Document Type: Article

References (16)

1. Frankel SR, Eardley A, Heller G, Berman E, Miller HW Jr, Dmitrovsky E, Warrell RP Jr: All-trans retinoic acid for acute promyelocytic leukemia: Results of the New York study. Ann Intern Med 120:278, 1994
2. Fenaux P, Castaigne S, Chomienne C, Dombret H, Degos L: All trans retinoic acid treatment for patients with acute promyelocytic leukemia. Leukemia 6:64, 1992 (suppl 1)
3. Warrell RP Jr: Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies and implications. Blood 82:1949, 1993
4. Muindi J, Frankel SR, Miller WH Jr, Jakubowski A, Scheinberg DA, Young CW, Dmitrovsky E, Warrell RP Jr: Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood 79:299, 1992
5. Muindi JF, Scher HI, Rigas JR, Warrell RP Jr, Young CW: Elevated plasma lipid peroxide content correlates with rapid plasma clearance of all-trans-retinoic acid in patients with advanced cancer. Cancer Res 54:2125, 1994
6. Mehta K, Sadeghi T, McQueen T, Lopez-Berestein G: Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. Leukemia Res 18:587, 1994
7. Weinstein JN: Liposomes as drug carriers in cancer therapy. Cancer Treat Rep 68:127, 1984
8. Hirschel-Scholz S, Siegenthaler G, Saurat JH: Isotretinoin differs from other synthetic retinoids in its modulation of cellular retinoic acid-binding protein. Br J Dermatol 120:639, 1989
9. Lopez-Berestein G, Rosenblum M, Sadeghi T, Mehta K: Pharmacokinetics, tissue distribution, and toxicology of tretinoin incorporated in liposomes. J Liposome Res 4:689, 1994
10. Drach J, Lopez-Berestein G, McQueen T, Andreeff M, Mehta K: Induction of differentiation in myeloid cell lines and acute promyelocytic cells by liposomal all-trans retinoic acid. Cancer Res 53:2100, 1993
11. Muindi JRF, Frankel SR, Huselton C, DeGrazia F, Garland W, Young CW, Warrell RP Jr: Clinical pharmacology of all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 52:2138, 1992
12. Lefebvre P, Thomas G, Gourmel B, Agadir A, Castaigne S, Dreux C, Degos L, Chomienne C: Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Leukemia 5:1054, 1991
13. Ghosh BK: A comparison of some approximate confidence intervals for the binomial parameter. J Am Stat Assoc 74:894, 1979
14. Eriksson V: Extra and intracellular transport of retinoids, in Hilderson H (ed): Subcellular Biochemistry, vol 16. New York, NY. Plenum, 1990
15. Kurzrock R, Estey E, Talpaz M: All-trans retinoic acid: Tolerance and biologic effects in myelodysplastic syndrome. J Clin Oncol 11:1489, 1993
16. Delva L, Cornic M, Balitrand N, Guidez F, Midea JM, Delmar A, Teillet F, Fenaux P, Castaigne S, Degos L, Chomienne C: Resistance to all-trans retinoic acid therapy in relapsing acute promyelocytic leukemia: Study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemia cells. Blood 82:2175, 1993